Related Experiment Videos
Resynchronization therapy for the management of heart failure
Barbara Leeper1, Darlene Legge
1Cardiovascular Services, Baylor University Medical Center, 3200 Gaston Avenue, Dallas, TX 75246, USA. bobbil@baylorhealth.edu
Critical Care Nursing Clinics of North America
|January 14, 2004
Summary
Biventricular pacing can help heart failure (HF) patients, but optimal patient selection, pacing techniques, and long-term benefits like improved survival and cost-effectiveness require further research.
Area of Science:
- Cardiology
- Biomedical Engineering
Background:
- Heart failure (HF) is a significant clinical challenge.
- Biventricular pacing (BVP) is a therapeutic option for select HF patients.
- Uncertainty exists regarding optimal patient selection and BVP efficacy.
Purpose of the Study:
- To identify the ideal patient profile for biventricular pacing.
- To determine optimal electrical configurations and pacing sites.
- To evaluate the impact of BVP on mortality and cost-effectiveness in heart failure.
Main Methods:
- Ongoing clinical studies are investigating BVP in heart failure.
- Research focuses on patient stratification and device optimization.
- Analysis includes quality of life, survival rates, and economic impact.
Main Results:
- Current indications for BVP exist but do not define the ideal patient group.
- Optimal pacing parameters and sites remain under investigation.
- Evidence regarding mortality benefit and cost-effectiveness is still being gathered.
Conclusions:
- Biventricular pacing shows promise for improving quality of life and survival in high-risk heart failure patients.
- Further research is needed to answer key questions about patient selection, technique, and long-term outcomes.
- Ongoing studies aim to provide definitive answers on BVP's role in heart failure management.